Advertisement

Index by author

July 01, 2019; Volume 71,Issue 3

A

  1. Anagnostaras, Stephan G.

    1. Cognitive Effects of MDMA in Laboratory Animals: A Systematic Review Focusing on Dose
      Madeline M. Pantoni and Stephan G. Anagnostaras
      Timothy A. Esbenshade, ASSOCIATE EDITOR
      Pharmacological Reviews July 2019, 71 (3) 413-449; DOI: https://doi.org/10.1124/pr.118.017087

  2. Antonioli, Luca

    1. The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases
      Luca Antonioli, Corrado Blandizzi, Pál Pacher and György Haskó
      Clive Page, ASSOCIATE EDITOR
      Pharmacological Reviews July 2019, 71 (3) 345-382; DOI: https://doi.org/10.1124/pr.117.014878

B

  1. Barker, Eric L.

    1. Open Access
      REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
      R. L. Carhart-Harris and K. J. Friston
      Eric L. Barker, ASSOCIATE EDITOR
      Pharmacological Reviews July 2019, 71 (3) 316-344; DOI: https://doi.org/10.1124/pr.118.017160

  2. Beaulieu, Jean-Martin

    1. Open Access
      5-HT3 Receptor Antagonists in Neurologic and Neuropsychiatric Disorders: The Iceberg Still Lies beneath the Surface
      Gohar Fakhfouri, Reza Rahimian, Jonas Dyhrfjeld-Johnsen, Mohammad Reza Zirak and Jean-Martin Beaulieu
      Jeffrey M. Witkin, ASSOCIATE EDITOR
      Pharmacological Reviews July 2019, 71 (3) 383-412; DOI: https://doi.org/10.1124/pr.118.015487

  3. Blandizzi, Corrado

    1. The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases
      Luca Antonioli, Corrado Blandizzi, Pál Pacher and György Haskó
      Clive Page, ASSOCIATE EDITOR
      Pharmacological Reviews July 2019, 71 (3) 345-382; DOI: https://doi.org/10.1124/pr.117.014878

C

  1. Carhart-Harris, R. L.

    1. Open Access
      REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
      R. L. Carhart-Harris and K. J. Friston
      Eric L. Barker, ASSOCIATE EDITOR
      Pharmacological Reviews July 2019, 71 (3) 316-344; DOI: https://doi.org/10.1124/pr.118.017160

D

  1. Dyhrfjeld-Johnsen, Jonas

    1. Open Access
      5-HT3 Receptor Antagonists in Neurologic and Neuropsychiatric Disorders: The Iceberg Still Lies beneath the Surface
      Gohar Fakhfouri, Reza Rahimian, Jonas Dyhrfjeld-Johnsen, Mohammad Reza Zirak and Jean-Martin Beaulieu
      Jeffrey M. Witkin, ASSOCIATE EDITOR
      Pharmacological Reviews July 2019, 71 (3) 383-412; DOI: https://doi.org/10.1124/pr.118.015487

E

  1. Esbenshade, Timothy A.

    1. Cognitive Effects of MDMA in Laboratory Animals: A Systematic Review Focusing on Dose
      Madeline M. Pantoni and Stephan G. Anagnostaras
      Timothy A. Esbenshade, ASSOCIATE EDITOR
      Pharmacological Reviews July 2019, 71 (3) 413-449; DOI: https://doi.org/10.1124/pr.118.017087

F

  1. Fakhfouri, Gohar

    1. Open Access
      5-HT3 Receptor Antagonists in Neurologic and Neuropsychiatric Disorders: The Iceberg Still Lies beneath the Surface
      Gohar Fakhfouri, Reza Rahimian, Jonas Dyhrfjeld-Johnsen, Mohammad Reza Zirak and Jean-Martin Beaulieu
      Jeffrey M. Witkin, ASSOCIATE EDITOR
      Pharmacological Reviews July 2019, 71 (3) 383-412; DOI: https://doi.org/10.1124/pr.118.015487

  2. Friston, K. J.

    1. Open Access
      REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
      R. L. Carhart-Harris and K. J. Friston
      Eric L. Barker, ASSOCIATE EDITOR
      Pharmacological Reviews July 2019, 71 (3) 316-344; DOI: https://doi.org/10.1124/pr.118.017160

H

  1. Haskó, György

    1. The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases
      Luca Antonioli, Corrado Blandizzi, Pál Pacher and György Haskó
      Clive Page, ASSOCIATE EDITOR
      Pharmacological Reviews July 2019, 71 (3) 345-382; DOI: https://doi.org/10.1124/pr.117.014878

P

  1. Pacher, Pál

    1. The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases
      Luca Antonioli, Corrado Blandizzi, Pál Pacher and György Haskó
      Clive Page, ASSOCIATE EDITOR
      Pharmacological Reviews July 2019, 71 (3) 345-382; DOI: https://doi.org/10.1124/pr.117.014878

  2. Page, Clive

    1. The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases
      Luca Antonioli, Corrado Blandizzi, Pál Pacher and György Haskó
      Clive Page, ASSOCIATE EDITOR
      Pharmacological Reviews July 2019, 71 (3) 345-382; DOI: https://doi.org/10.1124/pr.117.014878

  3. Pantoni, Madeline M.

    1. Cognitive Effects of MDMA in Laboratory Animals: A Systematic Review Focusing on Dose
      Madeline M. Pantoni and Stephan G. Anagnostaras
      Timothy A. Esbenshade, ASSOCIATE EDITOR
      Pharmacological Reviews July 2019, 71 (3) 413-449; DOI: https://doi.org/10.1124/pr.118.017087

R

  1. Rahimian, Reza

    1. Open Access
      5-HT3 Receptor Antagonists in Neurologic and Neuropsychiatric Disorders: The Iceberg Still Lies beneath the Surface
      Gohar Fakhfouri, Reza Rahimian, Jonas Dyhrfjeld-Johnsen, Mohammad Reza Zirak and Jean-Martin Beaulieu
      Jeffrey M. Witkin, ASSOCIATE EDITOR
      Pharmacological Reviews July 2019, 71 (3) 383-412; DOI: https://doi.org/10.1124/pr.118.015487

W

  1. Witkin, Jeffrey M.

    1. Open Access
      5-HT3 Receptor Antagonists in Neurologic and Neuropsychiatric Disorders: The Iceberg Still Lies beneath the Surface
      Gohar Fakhfouri, Reza Rahimian, Jonas Dyhrfjeld-Johnsen, Mohammad Reza Zirak and Jean-Martin Beaulieu
      Jeffrey M. Witkin, ASSOCIATE EDITOR
      Pharmacological Reviews July 2019, 71 (3) 383-412; DOI: https://doi.org/10.1124/pr.118.015487

Z

  1. Zirak, Mohammad Reza

    1. Open Access
      5-HT3 Receptor Antagonists in Neurologic and Neuropsychiatric Disorders: The Iceberg Still Lies beneath the Surface
      Gohar Fakhfouri, Reza Rahimian, Jonas Dyhrfjeld-Johnsen, Mohammad Reza Zirak and Jean-Martin Beaulieu
      Jeffrey M. Witkin, ASSOCIATE EDITOR
      Pharmacological Reviews July 2019, 71 (3) 383-412; DOI: https://doi.org/10.1124/pr.118.015487
Back to top

In this issue

Advertisement